TREA

Narendra BAM

Follow

Person

  • King of Prussia, PA, US
People

Patents Grantslast 30 patents

  • Information Patent Grant

    Biopharmaceutical compositions
    • Patent number 12,187,789
    • Issue date Jan 7, 2025
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Myrna A. Monck
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Biopharmaceutical compositions
    • Patent number 12,187,791
    • Issue date Jan 7, 2025
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Myrna A. Monck
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Biopharmaceutical compositions
    • Patent number 12,187,790
    • Issue date Jan 7, 2025
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Myrna A. Monck
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Biopharmaceutical compositions
    • Patent number 11,459,384
    • Issue date Oct 4, 2022
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Myrna A. Monck
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Biopharmaceutical compositions
    • Patent number 11,299,541
    • Issue date Apr 12, 2022
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Myrna A. Monck
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Biopharmaceutical compositions
    • Patent number 11,286,298
    • Issue date Mar 29, 2022
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Myrna A. Monck
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Biopharmaceutical compositions
    • Patent number 11,274,148
    • Issue date Mar 15, 2022
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Myrna A. Monck
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Biopharmaceutical compositions comprising interleukin-5 antibody
    • Patent number 10,870,695
    • Issue date Dec 22, 2020
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Myrna A. Monck
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Method of treating cancer by administering conjugates comprising hu...
    • Patent number 7,736,639
    • Issue date Jun 15, 2010
    • Glaxosmithkline LLC
    • Narendra Bam
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Conjugates comprising human IL-18 and substitution mutants thereof
    • Patent number 7,311,902
    • Issue date Dec 25, 2007
    • SmithKline Beecham Corporation
    • Narendra Bam
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

  • Information Patent Application

    BIOPHARMACEUTICAL COMPOSITIONS
    • Publication number 20240294629
    • Publication date Sep 5, 2024
    • GlaxoSmithKline Intellectual Property (No.2) Limited
    • Myrna A. MONCK
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    BIOPHARMACEUTICAL COMPOSITIONS
    • Publication number 20240294628
    • Publication date Sep 5, 2024
    • GlaxoSmithKline Intellectual Property (No.2) Limited
    • Myrna A. MONCK
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    BIOPHARMACEUTICAL COMPOSITIONS
    • Publication number 20240294630
    • Publication date Sep 5, 2024
    • GlaxoSmithKline Intellectual Property (No.2) Limited
    • Myrna A. MONCK
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    BIOPHARMACEUTICAL COMPOSITIONS
    • Publication number 20220380452
    • Publication date Dec 1, 2022
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Myrna A. MONCK
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    BIOPHARMACEUTICAL COMPOSITIONS
    • Publication number 20220185878
    • Publication date Jun 16, 2022
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Myrna A. MONCK
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    BIOPHARMACEUTICAL COMPOSITIONS
    • Publication number 20210340246
    • Publication date Nov 4, 2021
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Myrna A. MONCK
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    BIOPHARMACEUTICAL COMPOSITIONS
    • Publication number 20210340247
    • Publication date Nov 4, 2021
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Myrna A. MONCK
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    BIOPHARMACEUTICAL COMPOSITIONS
    • Publication number 20210332125
    • Publication date Oct 28, 2021
    • Myrna A. Monck
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    BIOPHARMACEUTICAL COMPOSITIONS
    • Publication number 20200199219
    • Publication date Jun 25, 2020
    • GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED
    • Myrna A. MONCK
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    BIOPHARMACEUTICAL COMPOSITIONS
    • Publication number 20180251539
    • Publication date Sep 6, 2018
    • GlaxoSmithKline Intellectual Property (No.2) Limited
    • Myrna A. MONCK
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    METHOD OF TREATING CANCER BY ADMINISTERING CONJUGATES COMPRISING HU...
    • Publication number 20080206189
    • Publication date Aug 28, 2008
    • SmithKline Beecham Corporation
    • Narendra BAM
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    Conjugates comprising human IL-18 and substitution mutants thereof
    • Publication number 20050008615
    • Publication date Jan 13, 2005
    • Narendra Bam
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE